Global Arteriotomy Closure Devices Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

 What Market Size Is Projected For The Arteriotomy Closure Devices Market By 2030?

The arteriotomy closure devices market size has grown strongly in recent years. It will grow from $1.72 billion in 2025 to $1.84 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing volume of catheter-based interventions, wider adoption of minimally invasive angiography procedures, growth in cardiovascular disease prevalence, improved clinical acceptance of closure devices, expansion of interventional cardiology services.

The arteriotomy closure devices market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for next-generation vascular closure solutions, rising focus on reducing procedure-related complications, expansion of outpatient vascular procedures, growing investments in bioresorbable materials, increasing adoption of advanced closure technologies. Major trends in the forecast period include increasing adoption of suture-based closure devices, rising preference for radial access closure solutions, growing use of bioabsorbable hemostatic materials, expansion of minimally invasive vascular procedures, enhanced focus on faster patient recovery.

Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

What Drivers Are Contributing To The Expansion Trajectory Of The Arteriotomy Closure Devices Market?
The increase in the prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the arteriotomy closure devices market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders that affect the heart and blood vessels. The increase in the prevalence of cardiovascular diseases (CVDs) is largely due to rising rates of risk factors such as unhealthy diets, physical inactivity, and obesity, along with an aging population. Arteriotomy closure devices are essential in cardiovascular treatments as they quickly and securely close arterial puncture sites, reducing complications and improving recovery after procedures like angioplasties and catheterizations. For instance, in September 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million individuals are currently affected by heart and circulatory diseases, comprising 4 million men and 3.6 million women. By 2030, this number could increase by 1 million, and by 2040, it may rise to 2 million more than the current figures. Therefore, the increase in the prevalence of cardiovascular diseases (CVDs) is driving growth in the arteriotomy closure devices market.

Which Primary Segments Are Included In The Detailed Analysis Of The Arteriotomy Closure Devices Market?
The arteriotomy closure devices market covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices
2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures
3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:
1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices
2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

What New Trends Are Beginning To Take Shape Within The Arteriotomy Closure Devices Market?
Major companies operating in the arteriotomy closure devices market are prioritizing product innovation to enhance procedural efficiency, improve patient outcomes, and meet the rising demand for minimally invasive vascular access solutions. A mid-bore venous closure device is a medical tool designed to seal venous access sites created by mid-sized catheters or sheaths, promoting hemostasis and aiding in patient recovery after interventional procedures. For instance, in June 2024, Haemonetics Corp, a US-based healthcare company, expanded its VASCADE portfolio with the launch of the VASCADE MVP XL mid-bore venous closure device. This device, tailored for larger sheaths (10-12F, up to 15F outer diameter) used in procedures like cryoablation, incorporates 58% more collagen and a larger collapsible disc to achieve rapid hemostasis. Complementing Haemonetics' existing range of small- and mid-bore vascular closure solutions, this innovation underscores the company's leadership in advanced closure technologies.

Which Major Corporations Play A Crucial Role In The Arteriotomy Closure Devices Market Landscape?
Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Get Your In-Depth Arteriotomy Closure Devices Market Report Now:
https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Which Geographical Region Is Projected To Lead The Arteriotomy Closure Devices Market Throughout The Forecast Period?
North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn